Subchronic 90-day feeding studies were conducted in male and female Fischer-344 (F-344) rats on highly refined white mineral oils and waxes representative of those used for food applications. The goal was to help clarify the mixed results found in other toxicity studies with laboratory animals. Seven white oils and 5 waxes were fed at dietary doses of 20,000, 2,000, 200, and 20 ppm and compared with control groups on untreated diet; toxicity was assessed at 90 days and also after a reversal period of 28 days and/or 85 days. Higher molecular-sized hydrocarbons (microcrystalline waxes and the higher viscosity oils) were without biological effects. Paraffin waxes and lowto midviscosity oils produced biological effects that were inversely related to molecular weight, viscosity, and melting point; oil type and processing did not appear to be determinants. Biological effects were more pronounced in females than in males. Effects occurred mainly in the liver and mesenteric lymph nodes and included increased organ weights, microscopic inflammatory changes, and evidence for the presence of saturated mineral hydrocarbons in affected tissues. Inflammation of the cardiac mitral valve was also observed at high doses in rats treated with paraffin waxes. Further studies are required to elucidate the mechanism for the responses observed and the relevance of these inflammatory responses in the F-344 rat to other species, including humans.
INTRODUCTION
Highly refined mineral hydrocarbon oils and waxes have a long established history of safe use in applications related to food processing, food packaging, cosmetics, and pharmaceuticals (12) . The safety of food-grade mineral hydrocarbons came under scrutiny late in the 1980s, largely as a result of new data from 2 90-day feeding studies in Fischer-344 (F-344) rats (2) . As a result, additional 90-day feeding studies were conducted in F-344 rats and are collectively reported in this article.
Mineral hydrocarbons has been used as a generic term for chemicals derived from petroleum. Food-grade mineral hydrocarbon products can be prepared from naphthenic or paraffinic crude oil (10, 12, 23, 30, 37) that is distilled at atmospheric and then at reduced pressure, followed by extensive refining of selected fractions. A combination of purification processes are used; these include solvent extraction, treatment with strong acid (oleum) and filtration through activated clay (percolation), and/or hydrogenation. The severity of refining processes for foodgrade products removes nearly all aromatics and other impurities (sulfur, oxygen, metals, etc.).
White mineral oils are complex mixtures of saturated paraffinic hydrocarbons (predominantly branched chain alkanes) and naphthenic hydrocarbons (alkanes containing 1 or more saturated cyclic structures). The ratio of paraffinics to naphthenics and the molecular weight range determine the physical properties of white oils (such as viscosity, boiling point, density, and pour point). The production of white oils removes linear alkanes that can be used to produce paraffin waxes.
Food-grade paraffin waxes are saturated solid hydrocarbons that consist predominantly of linear alkanes, with varying proportions of branched alkanes and smaller amounts of cycloalkanes. Paraffin waxes can be classified as low or intermediate melting point waxes. Other indications of molecular weight/size are boiling range and/or viscosity. Low melting point waxes are derived from lower boiling oil distillates and have viscosities ranging from derived from higher boiling oil distillates, have higher average molecular weights, and have viscosities that range from 6 to 10 cSt at 100°C. Microcrystalline waxes are derived from the highest boiling petroleum fractions (vacuum residuum), have the highest average molecular weight, and have viscosities that range from 10 to 30 cSt at 100°C. Furthermore, microcrystalline waxes have the highest branched and cycloalkane content of the 3 wax categories.
Baldwin et al (2) reported effects in 90-day feeding studies in F-344 rats using naphthenic white oils (25.6 cSt acid-treated at 40°C and 69.2 cSt at 40°C hydrogenated oil) at dietary doses up to 20,000 ppm. Effects reported in the liver and mesenteric lymph nodes included increased organ weights, microscopic inflammatory changes, and evidence for the presence of saturated mineral hydrocarbons in affected tissues. All prior published and unpublished studies had been without effect. No effects were observed in 90-day feeding studies in Long-Evans rats and beagle dogs at doses up to 1,500 ppm of food-grade paraffinic white oils (3 hydrogenated oils at viscosities of 13.8, 31.6, and 65.9 cSt at 40°C and 1 acidtreated oil of 12.3 cSt at 40°C) (12, 34) . Likewise, subchronic 90-day gavage studies in Sprague-Dawley rats with an acid-treated naphthenic food-grade white oil (35.7 cSt viscosity at 40°C), used as a vehicle control, showed no effects (21) . Chronic feeding studies of various mineral hydrocarbons in strains of rats other than the F-344 also showed no adverse effects. These chronic studies include waxes fed to male and female Sprague-Dawley rats for up to 2 yr at 10% (100,000 ppm) in the diet (33) , petrolatum (a mixture of paraffinic hydrocarbons/wax and white oil) fed to male and female FDRL rats for up to 2 yr at 5% (50,000 ppm) in the diet (28) , and mineral oil fed to male and female rats (BD I, BD III, and W strains with similar heredity) for up to 500 days at 2.0% (20,000 ppm) in the diet (32) . These and other relevant studies were reviewed more extensively by the American Petroleum Institute (12) .
The objectives of this study were to confirm the findings of Baldwin et al (2) , to explore possible factors for the apparently disparate results of the earlier toxicity studies, and to provide a basis for new mechanistic and/or long-term studies. The F-344 rat strain was selected for comparison with the studies reported by Baldwin et al (2) . Test materials were selected to represent the range of highly refined, petroleum-derived food-grade hydrocarbons (white oils and waxes) currently marketed in the United States and Europe. Furthermore, factors such as crude oil type (naphthenic or paraffinic), refining method (acid treatment or hydrogenation), and viscosity (a function of molecular size and type) were also considered in the experimental design and selection of test materials.
MATERIALS AND METHODS

Test Animals and Maintenance
Male and female F-344 rats were obtained at approximately 4 wk of age from a barrier-maintained colony (Harlan Sprague Dawley Inc., Indianapolis, IN, USA, or Harlan Olac LTD, Bicester, Oxon, UK). Animal husbandry conditions were compliant with international standards of Good Laboratory Practices, including U.S. Food and Drug Administration regulations (43) . Animal rooms were maintained at 19-24°C with a relative humidity of 45-70% and a 12-hr light/dark cycle. Nutritionally adequate powdered diet (Rat and Mouse No. 1 Maintenance Diet, Special Diet Services Limited, Witham, Essex) and tap water were available ad libitum. Animals were acclimated for a minimum of 7 days and randomly assigned to treatment groups of 5 rats of the same sex per cage prior to treatment.
Test Materials
The spectrum of test materials and their physical properties are summarized in Table I . Test materials were stored in the dark at room temperature under an atmosphere of nitrogen.
Coconut oil was purchased from Sigma Chemical Company Limited (Poole, UK) for use as a &dquo;food control oil&dquo; in the first study only. The rationale for selecting coconut oil was that white oils and waxes are mixtures of saturated hydrocarbons (CnH2n+z)' with carbon numbers ranging from approximately C1s to Cso or greater.
Coconut oil is 92% saturated with 74% of carbon chains in the C12-C,, range (13) .
Test Diets
Test diets of 20,000, 2,000, 200, and 20 ppm were prepared by serial dilution from a 10% (100,000 ppm) premix. The white oils were added directly to the premix.
Because coconut oil was semisolid at room temperature, the coconut oil and diet were warmed to 40°C prior to mixing to facilitate even distribution. The samples of wax were solid and were first converted to a sprayed powder by drawing molten wax through an atomizer with a stream of liquid nitrogen (44) . The diet and powdered wax were cooled overnight to -20°C before mixing. Fresh diets were prepared weekly and stored at room temperature in sealed metal containers prior to use. Dietary concentration, homogeneity, and stability were confirmed analytically, as described later.
Study Design
A standard 90-day dietary feeding study was designed and conducted to be compliant with international regulatory guidelines for safety testing of products with potential for human ingestion.
Three independent studies, each with their own set of controls, were conducted by the British Industrial Biological Research Association (now BIBRA Toxicology International, Surrey, UK). The second and third studies were designed to provide more information on a white oil and waxes, respectively, that had physical properties intermediate to the test materials included in the first study. For the purpose of this report, the results for these 3 studies and the various related test materials are combined.
First Study. The first study was initiated in February 1991 on 6 white oils, 3 waxes, and coconut oil. Mineral hydrocarbon test materials were designated as N10A, N15H, P15H, N70A, N70H, P100H, LMPW, HSW, and HMPW (Table I) ; dietary dose levels were 20,000, 2,000, 200, and 20 ppm. Four categories of treatment groups were designated as the main, the reversal, the tissue level, and the tissue level reversal groups. The size of the main group was 20 rats/sex/dose for the treated groups and 60 rats/sex for the untreated control group. A reversal group (10 rats/sex for treated groups, 20 rats/sex for untreated controls) was added at the high dose only (20, OOOR) to assess whether or not effects observed at 90 days would reverse following 28 days without treatment. The tissue level group and tissue level reversal group were satellite groups (5 rats/sex) added for untreated controls and the high dose only to evaluate whether or not nonpolar hydrocarbons were accumulated in selected tissues.
Second Study. The second study was initiated in April 1992 on a white oil designated as P70H (Table I ). There were only 2 categories of treatment groups in this study: the main and the tissue level groups. The main group size was 20 rats/sex/untreated control or dose at doses of 20,000, 2,000, 200, and 20 ppm and 5 rats/sex at the high dose only for the tissue level group.
Third Study. The third study was initiated in May 1992 on 3 waxes designated as LMPW, MP, and IMPW (Table  I ). The 3 categories of treatment groups in this study were the main, the reversal, and the tissue level. In this study, the reversal group was treated for 90 days followed by 85 days with untreated diet. Group size was 20 rats/sex/ untreated control or dose for the main group, 10 rats/sex for the untreated control and the high dose for the reversal group (20,OOOR), and 5 rats/sex at the high dose only for the tissue level group. Fewer dietary concentration levels were used; IMPW and MP were administered at dietary concentrations of 20,000, 2,000, and 200 ppm and LMPW (as a repeat of the first study) at 20,000 ppm only.
Observations
In Life. For all studies, rats were observed daily for clinical signs of toxicity. Individual body weights were recorded pretest, twice weekly during treatment, and at necropsy. Food intake for each cage of rats was measured twice weekly and was used to estimate test material consumption for individual rats. All high-dose and control animals received ophthalmological examinations during the week preceding treatment and during the last week of treatment. Prior to necropsy, rats were fasted overnight, with water available.
Necropsy. At necropsy, each rat was weighed and then sacrificed by exsanguination from the dorsal aorta under barbiturate anaesthesia. All macroscopic abnormalities were noted during the necropsy.
Hematology. Blood samples were collected from the aorta of all rats in the main and reversal groups at necropsy and measured by routine laboratory procedures for mean cell volume, total erythrocyte count, hematocrit, hemoglobin concentration, differential leukocyte count, total leukocyte count, platelet count, prothrombin time, and reticulocyte count. Clinical Chemistry. Serum was separated from blood collected at necropsy from all rats in the main and reversal groups. Serum was analyzed by routine laboratory procedures for albumin, albumin/globulin ratio, total bilirubin, creatinine, electrolytes (calcium, chloride, phosphorus as phosphate, potassium, sodium), enzyme activity [alanine aminotransferase (ALAT), alkaline phosphatase (ALKP), aspartate aminotransferase (ASAT), gamma glutamyl transferase (GGT)], glucose, total protein, and urea.
Vitamin E. In the first study, plasma (separated from blood collected at necropsy from the tissue level group) was analyzed for vitamin E (a-tocopherol). Plasma samples were saponified, extracted with hexane, and analyzed by high-performance liquid chromatography using fluorimetric detection.
Organ Weights and Histopathology. The adrenal glands, brain, cecum (full and empty), heart, kidneys, liver, ovaries/testes, spleen, and thymus were weighed, and organ-to-body weight ratios were calculated for all rats in the main and reversal groups. In the first study, mesenteric lymph nodes were weighed only in the tissue level and tissue level reversal groups (20,000 ppm). In the second and third studies, mesenteric lymph nodes were weighed after fixation such that surrounding fatty tissue could be more easily dissected prior to weighing to reduce the variability in measured organ weight.
In all 3 studies, a complete and representative set of tissue samples was retained in 10% neutral-buffered formalin from all rats in the main and reversal groups. These tissues included adrenal glands, artery (aorta), bladder, brain, cecum, colon, cervix uteri, diaphragm, duodenum, epididymis, esophagus, extra orbital lachrymal glands, eye, femur, Harderian gland, heart, ileum (including Peyer's patches), jejunum, liver (representative samples from each lobe), lungs (with main stem bronchi), lymph nodes (axillary, cervical, mesenteric), mammary gland (inguinal region), nasal bones, nerve (sciatic taken together with surrounding muscle), ovaries, pancreas, perirenal fat, pin-t nae (retained for identification only), pituitary, prostate, f rectum, salivary gland, seminal vesicles, skeletal muscle, r skin (inguinal region), spinal cord, spleen, sternum, stom-i ach, testes, thymus, thyroid/parathyroid glands (retained i on trachea), tongue, trachea, uterine horns, vagina, and vein (posterior vena cava). In the first and second studies, t paraffin wax sections of all preserved tissue from control and high-dose rats, together with heart (LMPW only), 5 lung, liver, kidney, mesenteric lymph nodes, spleen, and j small intestine from all other treatment groups, were I stained with hematoxylin and eosin and subject to his-1 topathological examination. In the third study, micro- groups. Sections were stained with Herxheimer's Sudan IV and counterstained with hematoxylin. These sections were examined for the presence of Sudan IV-staining material as evidence for tissue accumulation of nonpolar hydrocarbons. In addition, sections from approximately one-third of the female rats from the control and highdose-treated groups were examined under polarized light for birefringent material as another form of evidence for the presence of hydrocarbons. Where birefringent material was seen in the main study group, all reversal animals from this group were also examined.
In the third study, hearts from male and female rats (5 each from the control and high-dose treatment groups in the main and reversal groups) were processed to provide sections of the mitral valve. Frozen sections, approximately 12 j.1m in thickness counterstained with hemalum, were prepared and examined microscopically using polarized light. Contiguous sections, approximately 500 j.1m in thickness, were processed to paraffin wax, stained with hematoxylin and eosin, and examined microscopically. The initial frozen sections were taken posterior to the mitral valve through the ventricles. The preceding procedure was repeated until the paraffin wax sections were anterior to the mitral valve through the auricles (approximately 3-4 levels).
Hydrocarbon Analyses
Dietary. The dietary concentrations of white oils and waxes were determined as described by Walters et al (44) . The detection limit by this method was 1 j.1g/g (0.0001 % or 1 ppm) in the diet, and control diet was found to contain around 0.003% (w/w, 30 ppm) background (44) . Tissue Levels. A variation of the procedure for dietary analysis was used for the tissue level and tissue level reversal group rats to quantify the presence of nonpolar hydrocarbons in selected tissues at a detection limit up to 10 j.1g/g (44) . In the first study, tissues were analyzed from weighed samples of perirenal fat (random sample), jdney (1 kidney), liver (first study: random samples rom periphery of all lobes; third study: whole liver), nesenteric lymph nodes (all tissue), and spleen (approxmately half). The perirenal fat sample was not analyzed n the second and third studies.
)tatistical Analyses
Where reported, average data are presented as mean ± standard error of the mean (SEM). Analysis of data for :ach study was performed using the following general procedures as appropriate. Continuous If no suitable transformation could be made, one of the preceding tests was selected as the most appropriate based on the nature and distribution of the data. In all test comparisons, a probability of p S 0.05 in a 2-sided test was considered to be statistically significant. Individual animal data identified as statistical outliers were removed from the analysis. Data from the histopathological examination were tested for an increase in incidence between treated and untreated control animals using Fisher's exact test. A probability level of p S 0.05 in a 1sided test was considered to be statistically significant.
RESULTS
In-Life Observations
No adverse effects of treatment were observed on the physical appearance or behavior of the rats during the study. Ophthalmological observations were unremarkable ; no findings indicative of treatment-related effects were observed.
Overall, body weight gain was not affected by treatment. Body weights for both male and female rats in various treatment groups showed occasional statistically significant differences from untreated control groups.
These differences were not considered to be treatmentrelated because they generally did not vary by more than 10%, were not consistent between the sexes in the different treatment group categories (i.e., main vs reversal group), did not persist throughout the treatment, and were not dose-related.
At the highest dose in both sexes, food consumption tended to show small, but statistically significant, increases. Generally, the increased food consumption did not exceed control values by more than 10% and disappeared during the reversal period. The incremental food consumption was assumed to reflect the caloric loss for bulk substitution of mineral hydrocarbons for feed in the tesi diets. Average test material consumption per kilogram (kg) body weight was slightly higher in female than in male rats by about 10%. Composite average daily intakes of test material for all studies at dietary doses of 20,000, 2,000, 200, and 20 ppm were approximately 1,815, 173, 17, and 1.7 mg/kg body weight/day in males and 1,951, 190, 19, and 2.0 mg/kg body weight/day in females, respectively.
Hematology
A number of hematological parameters were affected by treatment, with a greater response observed in females (Table II) .
Red Blood Cells. Females treated for 90 days with 2,000 and 20,000 ppm N10A and P15H, and 20,000 ppm N15H, N70A, N70H, and LMPW had small statistically significant decreases (-~-2---4%) in red blood cells (RBC) (Table II) , with a concomitant reduction in hemoglobin concentration and hematocrit (data not shown). These effects were reversible. Males showed no evidence for treatment-related effects, except for a 2% reduction in hemoglobin concentration in the 2,000-and 20,000-ppm LMPW treatment groups. An increased reticulocyte count (slightly >40%) was also observed in females treated with 20,000 ppm LMPW and IMPW and persisted in the reversal groups. No effects on RBC were noted in males and females treated with P70H, P100H, MP, HSW, and HMPW Coconut oil produced a small (2%) statistically significant decrease in RBC and hemoglobin in both sexes. There was no effect on mean cell volume.
White Blood Cells. A statistically significant increase in white blood cells (WBC) was observed at high doses in some female treatment groups (Table II ). An increase of about 20-25% for total WBC occurred in females treated with 20,000 ppm NI0A, N15H, P15H, MP, and HSW and with 2,000 ppm LMPW. A larger increase was observed for 20,000 ppm LMPW: a 48 and 34% increase over untreated controls in the first and third studies, respectively. The increase in total WBC was typified by an increase of neutrophils (except for HSW) and monocytes. Also, lymphocytes were increased by LMPW and HSW and eosinophils were reversibly increased by N10A, P15H, LMPW, and MP WBC remained elevated after the reversal period for rats treated with N15H, P15H, and LMPW and increased for the P 100H and IMPW reversal groups. Total WBC were increased by 17-20% in males treated with 20,000 ppm N15H and P15H only. Male and female groups treated with N70A, N70H, P70H, P100H, and HMPW were without any significant effects for total and differential WBC in the main study groups. . Platelets. Platelets were decreased by 5-20% in male and female rats treated for 90 days with 20,000 and 2,000 ppm LMPW, MP, IMPW, and HSW (females only, data not shown). The magnitude was slightly less in males and was reversible (returned to control values) in males after 85 days. Statistically significant changes that occurred in other groups were sporadic, unrelated to dose, and not considered to be treatment-related. There was no treatment effect on prothrombin time in either sex.
Clinical Chemistry
Dose-related and statistically significant clinical chemistry data for enzyme activity (ALAT, ASAT, and GGT) are summarized in Table II for females relative to untreated controls. Only the groups treated with LMPW and MP showed a dose response at 2,000 and 20,000 ppm; groups treated with N10A, N15H, P15H, P70H, P100H, and IMPW had a smaller response at 20,000 ppm only for 1 or more of these enzymes. In males (data not shown) treated with LMPW, MP, and IMPW only, the elevated enzyme levels for ALAT and ASAT were similar or slightly higher than those of females. GGT was elevated in females only at the 20,000-ppm doses of N10A, N15H, P15H, and MP and at 2,000 and 20,000 ppm LMPW for females and males. ALAT, ASAT, and GGT were not elevated in other male treatment groups. Values for ALAT and ASAT decreased following the 28and 85-day reversal periods in all groups except IMPW, whereas the value for GGT increased.
Other clinical chemistry changes were smaller in magnitude, generally without dose response, but noted to be statistically significant. (Data are not shown but summarized in text.) Serum enzyme levels for ALKP were decreased by 5-15% at the 2,000-and 20,000-ppm doses for N10A, N15H, and P15H in both sexes, and in males for MP and IMPW, and also at 20,000 ppm for LMPW for both sexes and for IMPW in females. Reversibility was variable and was observed in females treated with NI0A, P15H, and IMPW, and in males treated with MP and IMPW Glucose levels were slightly increased (up to 16%) in almost all of the female treatment groups (but not males) at doses of 20, 200, and 2,000 ppm, in addition to the 20,000-ppm reversal group rats, but not the 20,000-ppm main group.
Albumin/globulin ratios were decreased by 6-19% in female rats treated with 2,000 and 20,000 ppm P15H and LMPW and with 20,000 ppm NI0A, N15H, N70A, and MP. In males, albumin/globulin ratios were decreased in the 20,000-ppm LMPW and MP groups. Albumin was decreased by 3-12% in females treated with 2,000 and 20,000 ppm P15H, LMPW, MP, and HSW and with 20,000 ppm N70A and IMPW. In males, albumin was increased by 2-4% in groups treated with 2,000 and 20,000 ppm LMPW and with 20,000 ppm N10A and N15H. Total protein was decreased by 3-5% in female rats treated with 2,000 and 20,000 ppm LMPW and with 20,000 ppm MP These endpoints did not completely reverse after the 28-day reversal but did reverse after the 85-day reversal period in Study 3 with the waxes. All other clinical chemistry endpoints (electrolytes, creatinine, and urea) showed no changes that were considered to be treatment-related in either sex.
Vitamin E
Serum vitamin E concentrations were measured in the high-dose main and reversal groups (first study only) to assess the potential impact of dietary administration of white oils on fat-soluble nutrients. Untreated males had slightly lower serum vitamin E concentrations than females : 5.0 ± 0.7 and 7.2 -~ 1.7 j.1g/ml, respectively. Concentrations were decreased in groups treated with N10A, N15H, and P15H to approximately 30% of control in males and 45% in females. Intermediateand high-viscosity oils (N70A, N70H, and P100H) had a lesser effect; values for males were 40-50% and for females were 50-70% of the control. With the LMPW, there was about a 30% increase for both males and females. No effects were seen with the 2 microcrystalline waxes (HSW and HMPW). Coconut oil increased serum vitamin E about 25% in females only. After the 28-day reversal, all serum vitamin E concentrations were not significantly different from untreated controls for all treatment groups except males treated with N 1 OA and N70H, where values remained decreased by 16 and 12%, respectively.
Organ Weights
The organ weights of adrenals, brain, cecum full, cecum empty, heart, ovaries, testes, and thymus were not &dquo; ~°~ ~° ~°~ the first y affected by treatment. There were sporadic statistically significant changes in absolute and/or relative organ weight. However, they were not considered to be treatment-related in the absence of a dose-related trend, when data were not consistent for absolute versus relative weights, or when data were not consistent for high-dose groups used for the main study group compared to the tissue level high-dose groups. Statistically significant increases of organ weights were observed for kidney, liver, mesenteric lymph node, and spleen; effects are detailed later.
In general, absolute and relative liver weights were significantly increased at doses of 2,000 ppm and higher for the lower viscosity oils (NI0A, N15H, and P15H), N70A, LMPW, MP, and IMPW. Figure 1 illustrates the changes in relative liver weights for the female groups only. The increased liver weight tended to be greater in females than in males. For example, there was approximately a 25% increase in relative weight in females compared to an average increase of 12% for males, at 20,000 ppm for low-viscosity oils and LMPW. The magnitude of any effect was generally less in the reversal groups but often remained in excess of controls, especially in females.
Mesenteric lymph node weights (absolute and relative) were increased more than 2.5-fold (>250%) in female rats treated with 20,000 ppm N10A, N15H, P15H, LMPW, MP, and IMPW (Fig. 2 ). There was little evidence for reversal of the weight increase after 28 days, and there was a slight increase for some treatment groups (N70A, N70H, HSW, and HMPW). However, in the third study with waxes where there was an 85-day reversal, the weights were significantly decreased though still statistically higher than controls. Responses in males were qualitatively similar but less in magnitude.
Spleen weights (absolute and relative) were significantly greater than control for females and males treated with 20,000 ppm N 10A, N15H, P 15H, N70A, N70H, P70H, LMPW, MP, and IMPW (Fig. 3 ). Again, the response in males was qualitatively similar but less in magnitude than in females. Smaller but significant increases also were observed at 2,000 ppm for LMPW (both sexes) and IMPW (females). In females, spleen weights remained increased after a 28-day reversal for oils and after an 85-day reversal for waxes. In males after the 28-and 85-day reversals, spleen weights were not statistically significant from untreated control values except for the LMPW treatment group. (20, OOOR) . Data represent the composite of 3 separate studies; mesenteric lymph node weights were measured only in the 20,000and 20,OOOR-ppm groups in the first study. The group designated as CO was the coconut oil biological control from the first study. Asterisk (*) indicates values significantly different from the untreated control at p S 0.05. in the high-dose male and female groups for N 10A, N15H, P15H, and N70H (females only). Other sporadic statistically significant changes occurred but did not appear to be related to treatment. These differences reversed after 28 days. Overall, the magnitude of kidney weight increases was similar in males and females.
Histopathology
Four of the test materials, 2 oils (P70H and P 100H) and 2 waxes (HSW and HMPW), did not elicit any treatment-related histopathological effects (Table III) . When observed in other groups, histopathologic effects consistently occurred in the liver and mesenteric lymph nodes, and these are described in detail later. In general, the effects were qualitatively similar to one another but differed in magnitude depending on the nature of the test material. The effects were dose-related, were of greater magnitude in females than in males, and were greater with the lower molecular weight test materials.
In addition to the changes in liver and mesenteric lymph nodes, rats treated with the higher doses of LMPW, MP, and IMPW were observed to have treatmentrelated changes in the cervical lymph nodes and cardiac mitral valve (Table III ; note that not all the cardiac mitral valve effects were statistically significant for IMPW). In the first study, LMPW produced treatment-related changes in the small intestine, but this was not evaluated in the third study on waxes where the histopathology was focused on liver, lymph nodes (mesenteric and cervical), heart, and tissues with macroscopic abnormalities. All other findings were not statistically significant or were not considered to be treatment-related or of biological significance. Histopathological evidence for the presence of hydrocarbons (as indicated by Sudan IV staining and/ or the observation of birefringent material under polarized light) was variable and most often observed in animals treated with LMPW (details later).
Liver. Histopathological effects observed in the liver were classified by size as granulomas or microgranulomas (Fig. 4 ). Granulomas consisted of focal collections of macrophages surrounded by inflammatory cells, occasional necrotic cells, and variable fibrosis. Microgranulomas were small collections of macrophages (three to five) with a few lymphocytes at the periphery and had an average diameter less than 25% of the average hepatic lobule. It appeared that these effects were not evenly distributed within or between lobes of the liver, they were larger and more abundant in the portal area, and the cau- dal lobe often appeared to be most affected. When hepatic microgranulomas and/or granulomas were present in animals, they were qualitatively graded as few or many. For summarizing the data in Table III , each animal examined was included in a summary incidence table based on the most severe effect recorded (few microgranuloma < many microgranuloma < few granuloma < many granuloma). These observations were graded 1-4 (respectively), summed, divided by the number of animals observed, and multiplied by 100 to derive the values shown in Table III . Thus, a score of 400 would be the maximum and indicate that all rats in a treatment group were categorized as &dquo;granuloma, many.&dquo;
The incidence of rats with hepatic effects (microgranulomas and/or granulomas) was increased in males and females by 2,000 and 20,000 ppm LMPW, MP, and IMPW and in females only by 20,000 ppm N10A, N15H, N70A, and N70H. There was no evidence of Sudan IV staining of granulomas in liver; however, the intensity of staining in periportal hepatocytes was increased in both sexes treated with LMPW and in males with HSW. In females treated with LMPW, birefringent material was observed under polarized light within hepatocytes and Kupffer cells in the portal tract areas and in some, but not all, granulomas and foci of inflammatory cells.
There was some evidence for the attenuation of the hepatic effects in both males and females for most test materials after a 28-day reversal (20,OOOR, Table III ). This was seen as fewer granulomas/microgranulomas observed and/or a trend for fewer granulomas with a concomitant increase in microgranulomas (data not shown). However, the incidence of animals showing some effect typically remained the same or increased after 28 days (some increase was seen in females treated with P15H, N70A, and N70H). Distribution of birefringent material was still diffusely present in females treated with LMPW. After the 85-day reversal period in the third study, the evidence for attenuation of effects was more apparent. In the liver of both male and female rats, microgranuloma were still present, but there was little to no evidence of parenchymal cell necrosis nor a chronic inflammatory response. Foci of histiocytes were also present, but there was no associated inflammatory reaction. The foci and macrophages within the microgranuloma were usually pigmented.
Me.renteric Lymph Nodes. Histopathological effects in the mesenteric lymph nodes consisted of focal collections of macrophages, often in the cortical region. The macrophages were lightly vacuolated with a slightly foamy appearance to the cytoplasm. Some yellowish brown pigmentation of varied intensity. The focal collections of macrophages were classified as histiocytosis and were scored as &dquo;minimal,&dquo; &dquo;mild,&dquo; &dquo;moderate,&dquo; or &dquo;marked&dquo; on the basis of size and abundance ( Fig. 5 ). To derive the values shown in Table III , these observations were graded 1-4, summed, divided by the number of animals observed, and multiplied by 100. The foci of histiocytosis were not homogeneously distributed but were often restricted to 1 node, or even to part of 1 node, with some areas markedly affected and others relatively free of effect. Thus, detection of this effect was subject to variability and the reported values may only represent an approximation of the true incidence. Histiocytosis, classified as &dquo;minimal&dquo; or occasionally &dquo;mild,&dquo; was found in the mesenteric lymph nodes of control rats at an incidence ranging up to 31 % in males and 37% in females in these collective studies.
Histiocytosis (incidence and severity) was significantly increased, compared with controls, in males fed diets that contained N15H at doses of 20 ppm or above, P15H, LMPW, MP, and IMPW at doses of 200 ppm or above, and N10A, N70A, and N70H at doses of 2,000 ppm or above (Table III) . Likewise, histiocytosis was significantly increased in females fed diets with LMPW at 20 ppm or above and with N10A, N15H, P15H, N70A, N70H, MP, and IMPW at 200 ppm or above. The obser-vations for P70H, P100H, HSW, and HMPW were indistinguishable from control at any dose level in either sex. There was variable evidence for Sudan IV staining in some histiocytic foci, and the incidence of foci that stained was increased in groups receiving P100H, HSW, HMPW, and coconut oil. Birefringent material (observed under polarized light) was observed within some (but not all) histiocytic foci and beneath the capsule of mesenteric lymph nodes.
Evidence for attenuation of effects in the mesenteric lymph nodes was variable in the reversal groups (Table   III ). In males, there tended to be an increase in incidence and rating of the effects after the 28-day reversal. A decreased rating but generally constant incidence was observed for females after the 28-day reversal in the NlOA, N15H, P15H, and LMPW treatment groups. In contrast, for female rats treated with N70A and N70H, there tended to be an increase in incidence and rating of effects after the 28-day reversal. Birefringent material was still observed in 28-day reversal females treated with LMPW within the subcapsular region, within some foci of histiocytosis, and within the medullary cords and sinuses. After the 85-day reversal (third study), there was an attenuation of effects for all male treatment groups and for females treated with LMPW and MP but an increase for the IMPW female treatment group. Furthermore, after the 85- day reversal, the morphological appearance had changed; the histiocytic foci were usually pigmented, the outlines of the foci were less well defined, and the histiocytes appeared more vacuolated than in the main study.
Cardiac Mitral Valve. Focal inflammation was observed within the cusps of the cardiac mitral valve of rats treated with some of the lower melting point waxes (Table III and Fig. 6 ). This response was confined to the mitral valve and was not associated with the myocardium. Histologically, there was an increased cellularity and thickening of the valve with destruction of the fibrous core. A mixed population of cells (macrophages, plasma cells, and lymphocytes), pyknotic nuclei, mitotic figures, and cell debris was associated with the inflammation.
A statistically significant incidence of cardiac mitral valve inflammation was observed in males and females treated with 20,000 ppm LMPW and females treated with 2,000 ppm LMPW in the first study. In the subsequent study of waxes (third study), only 5 of the high-dose animals were evaluated for the presence of this effect, and it was observed in nearly all 5 of the males and females examined from the groups treated with 20,000 ppm LMPW and MP and 2 of 5 females treated with IMPW. Examination of frozen sections from this tissue under a polarizing microscope revealed the presence of birefringent material in the cardiac mitral valves of ani-mals treated with LMPW and MP (5/5 males and females) and IMPW (5/5 females), which was not always associated with cardiac mitral valve inflammation.
In the first study after the 28-day reversal, incidences of cardiac mitral valve inflammation in both male and female rats treated with LMPW remained increased. In the third study after the 85-day reversal, the incidence for LMPW and MP reversal groups remained the same, and the incidence appeared to increase for IMPW (from 0/5 to 2/5 for males and from 2/5 to 3/5 for females; Table   III ). The occurrence of birefringent material was reduced in the 85-day reversal groups to 3 in 5 for LMPW females and 0 in 5 for LMPW males, 1 in 5 for IMPW (both sexes), and not observed for MP males or females (data not shown).
Cervical Lymph Nodes. Statistically significant increases of rats with histiocytosis observed in cervical lymph nodes was observed only in the third study on waxes. The incidence and severity of cervical lymph node histiocytosis were less than that observed in the mesenteric lymph nodes and were greater in females than in males. The incidence was statistically significant only in the high-dose males (LMPW and MP only) and females (LMPW, MP, and IMPW). After the 85-day reversal, the incidence and severity were reduced, and the in- Small Intestine. Statistically significant increased incidences of rats with macrophage accumulation in Peyer's patches were observed in both males and females receiving LMPW at 2,000 and 20,000 ppm in the first study. (This tissue was not evaluated in the third study on the waxes LMPW, IMPW, and MP) Also, a statistically significant increase of female rats with macrophage infiltration of the lamina propria was observed in the high-dose LMPW group. A statistically significant increase of female rats with vacuolation of the lamina propria was seen in the high-dose N l0A group. The incidence of rats with Sudan IV staining of Peyer's patches showed a statistically significant increase in some treatment groups (main group males treated with N10A, P15H, N70A, and P100H; no female groups; no reversal groups of either sex) but was unrelated to those groups with macrophage accumulation. The presence of birefringent material, evaluated in females only, was observed in some areas of the small intestine (submucosa of the villi, the lamina propria, and within Peyer's patches) of rats treated with LMPW in the main and 28-day reversal groups.
Tissue Analyses for Nonpolar Hydrocarbons
Saturated hydrocarbons were detected in liver, mesenteric lymph nodes, and perirenal fat (Table IV, females only); levels in the spleen and kidney were much less and did not exceed 0.1 mg/g tissue. Because the analytical technique used carbon tetrachloride extraction and infra-red detection, unambiguous identification of the test material could not be determined.
In the liver, saturated hydrocarbon content ranged from 7.6 to 16.9 mg/g liver in females (Table IV) treated with LMPW, MP, and IMPW and were about 1.5-2 times greater than values for males (4.5-7.6 mg/g liver in males, data not shown). For oil groups where statistically significant increases of saturated hydrocarbons were observed (NI0A, N15H, P15H, N70A, N70H, and P70H), tissue content ranged from 1.0 to 4.3 mg/g liver in females and were 4-5 times greater than males (0.3-1.0 mg/g liver in males; data not shown). Dietary treatment with P100H, HSW, and HMPW did not produce statistically significant increases of liver-saturated hydrocarbon content. For treatment groups with statistically significant increases, tissue content was reduced by about 10-30% (females) and 35-50% (males; data not shown) in the white oil groups and by about 50-60% (females) and 30-50% (males, data not shown) for the LMPW and HSW waxes. After the 85-day reversal, tissue content was reduced by a greater extent (80-90% reduction in females for the LMPW, IMPW, and MP waxes; not measured in males). In mesenteric lymph nodes, statistically significant increases of saturated hydrocarbons occurred in the same treatment groups as for the liver (Table IV, shows female data only). Saturated hydrocarbon contents ranged up to 4.2 mg/g tissue and were higher in females than in males. Overall, the 28-day reversal data did not show a reduction of the content of saturated hydrocarbon in mesenteric lymph nodes, and data were not available for the 85-day reversal groups. Standard errors were high relative to the mean values and reflect initial difficulties in dissecting sufficient quantities of mesenteric lymph nodes from surrounding tissue. In the second and third studies, the dissection technique was improved by immersing the mesenteric fat pads, which contain the mesenteric lymph nodes, in formalin prior to dissection. This fixed and firmed the nodes relative to the surrounding fats and facilitated their complete dissection.
In samples of perirenal fat, saturated hydrocarbon content was increased to a similar extent in males and females treated with LMPW, N 10A, N 15H, and P15H (Table IV, female data only). There was limited evidence for reversal after 28 days. Other treatment groups were not statistically different from controls. DISCUSSION Subchronic 90-day feeding studies of lowto intermediate-viscosity white oils and paraffin waxes at dietary doses up to 20,000 ppm produced biological effects in F-observed between average molecular weight and magnitude of biological response. For example, P70H, N70A, and N70H were 3 oils that had similar viscosities, but the P70H had a higher average molecular weight than either the N70A or N70H (485 vs 410 or 420). The P70H did not cause either liver granuloma or dose-dependent histiocytosis in the mesenteric lymph nodes at dose levels up to 20,000 ppm, in contrast to effects observed with N70A and N70H. Likewise, the biological effects of N70A and N70H were less than those of the lower molecular weight oils (N10A, N15H, and P15H). Similarly, for the waxes, IMPW and MP with higher average molecular weights (489 and 500, respectively) than LMPW (375) elicited fewer and less marked effects than LMPW.
There are considerable data to indicate that these effects produced by dietary mineral hydrocarbons exhibit strain and species differences. For example, in a tissueby-tissue reevaluation of histopathology (liver, mesenteric lymph nodes, and spleen) at overlapping doses from 2 independent studies, effects were observed only in F-344 rats (500 and 5,000 ppm) and not in Long-Evans rats (1,500 ppm) fed comparable-viscosity white oils (25 cSt and 12-14 cSt, respectively) for 90 days (34) . Likewise, in parallel studies with beagle dogs fed up to 1,500 ppm white oils (12-14 cSt) for 90 days, no treatment-related effects were observed, notably including an absence of histopathologic effects in liver and mesenteric lymph nodes (34) . The absence of histopathologic and other treatment-related effects also is consistent with historical chronic studies on white oils and waxes in Sprague-Dawley rats (100,000 ppm wax for 2 yr) (33) , in FDRL rats (50,000 ppm petrolatum for 2 yr) (28) , and in BD I, BD III, W strain rats (20,000 ppm white oil for up to 500 days) (32) . There are also other historic studies where the presence of Sudan-type staining and vacuolated cells in the small intestine, mesenteric lymph nodes, and liver of guinea pigs, rabbits, and rats (strain unspecified) fed very high daily doses of mineral oil did provide evidence for absorption and species differences but apparently without an inflammatory response such as that observed in the F-344 rat (36) .
Recently, a direct comparison was made between F-344 and Sprague-Dawley female rats fed 2,000 or 20,000 ppm P15H for 90 days (9) . While effects in F-344 rats were comparable to the results of this study and that by Baldwin et al (2) , effects in Sprague-Dawley rats were minimal. In Sprague-Dawley rats, no histologic effects were observed in the mesenteric lymph nodes at either dose, and effects in the liver were restricted to infiltrates of chronic inflammatory cells at the 20,000-ppm dose only with no evidence for the formation of discrete microgranuloma (9) . In the investigation by Firriolo et al (9) , the more extensive histopathologic response in F-344 rats was attributed to greater amounts of saturated hydrocarbons in the tissue and a greater inflammatory response in the F-344 rats. Indeed, when compared to other rat strains (Wistar and Sprague-Dawley), the F-344 rat appears to have a greater incidence of spontaneous granuloma in the mesenteric lymph nodes (46) . This was also apparent in a review of untreated F-344 rats from subchronic and chronic studies conducted by the U.S. Na-tional Toxicology Program (NTP) since 1981. A highly variable background incidence in untreated control F-344 rats was observed for liver granuloma (range 0-78%, mean = 15%, median = 20%) and mesenteric lymph node histiocytosis (range 0-100%, mean = 16%, median = 3%), with a higher incidence in females than in males (26) . These collective data suggest that F-344 rats may be predisposed to the development of inflammatory granulomatous lesions.
Although there are no reported chronic studies of mineral hydrocarbons in F-344 rats to date, there is a chronic oral gavage study in F-344 rats and B6C3F, mice on a chlorinated paraffin with a molecular size similar to the low molecular weight white oils and waxes (Cz3, 43% chlorine, CAS No. 63449-39-8) (27) . In this study, treatment-related increased incidences of liver granulomas (up to 100%) and mesenteric lymph node histiocytosis (up to 22%) was observed in F-344 rats with no apparent adverse effects on animal health or tumor incidence related to these effects at doses as high as 3,750 mg/kg/day in males and 900 mg/kg/day in females. The hepatic and lymphoid changes were not neoplastic, nor did they appear to be preneoplastic. Also of interest with respect to species differences was an absence of treatment-related liver and mesenteric lymph node effects indicating macrophage accumulation or other inflammatory changes in the B6C3F, mice at subchronic doses up to 7,000 mg/kg/ day and at chronic doses up to 5,000 mg/kg/day (27) .
While mineral hydrocarbons and lipid granuloma have been observed in human tissues, the consensus of those examining multiple human necropsy and/or biopsy cases is that the granulomas are considered to be clinically unimportant (4-6, 14, 47, 48) . Furthermore, the lipogranulomas that are observed in humans are pathologically distinct from the inflammatory lesions seen in the F-344 rat (47, 48) . In contrast to the F-344 rat response, human lipogranulomas have been described as benign, circumscribed lesions that contain mineral oil droplets in the center, but without evidence of inflammation, fibrosis, or clinically significant liver dysfunction (45) . Furthermore, accumulation in humans is not unique to mineral oil and also has been described for plant long-chain alkanes (such as those that occur in leaves or fruit peel cuticles and in nut and seed oils and waxes) and those that are produced by animals (such as butter fat, fish oils, beeswax, and lanolin) (3, 11, 17, 31, 42) .
For most effects, there was some evidence for reversibility of effects after the 28or 85-day reversal periods.
This could be seen as a decrease in the elevated organ weight, a decrease in the tissue content of saturated hydrocarbon, and/or a decrease in the incidence and/or severity of the histopathological observations. For the LMPW group, evidence for reversal of biological effects and tissue content of saturated hydrocarbon was more apparent after the 85-day reversal period than after the 28-day reversal period. This observation is consistent with metabolism of the absorbed hydrocarbon as described in other publications on oxidative metabolism and gradual elimination of representative hydrocarbons with time (7, 8, 15-17, 20, 38-41) . Likewise, these publications indicate that metabolism of hydrocarbons shows species differences and that metabolism is probably mediated by cytochrome P-450 in the liver and in the intestine of some species (7, 15, 20, 24, 29) . Limited reports suggest differences in pharmacokinetics of normal, branched, and cyclic hydrocarbons (18, (38) (39) (40) . However, interpretation of these studies is limited by the use of different molecular weight surrogate molecules, limited availability of appropriate surrogate hydrocarbons, and lack of analytical techniques with sufficient specificity and sensitivity to differentiate the molecules. The inflammatory response in the heart mitral valve by the highest doses of paraffin waxes has not been reported previously and its significance is unknown. Because routine histopathologic evaluation of the heart in toxicological studies does not consistently bisect the mitral valve, the historical control incidence of this response also is unknown. There were occasional observations of this response in control groups (Table III) . Furthermore, there are limited observations that suggest that the incidence of alterations in the subendocardial and pericardial regions of the heart may be increasing in various rat test models and some speculation that it may be related to adrenaline and rat handling practices (47) . Overall, there was a general consensus by various pathologists viewing the tissues from these studies that the cardiac lesions were not granulomatous, were of a different etiology or pathogenesis from those occurring in the liver and lymph nodes, and that there was no known counterpart in humans (47, 48) . Earlier studies have indicated that higher concentrations of mineral oil added to the diet, especially those low in fat, of experimental animals and humans can impair the availability of some fat-soluble nutrients (19, 22, 25, 35) . In this study, serum vitamin E concentrations were measured as a surrogate for other fat-soluble nutrients and were significantly decreased (up to a 70% decrease) in groups treated with the mineral oils. However, LMPW had the opposite effect on serum vitamin E than the mineral oils. Thus, in this study, the effects of supplemental dietary hydrocarbons on absorption of fat-soluble nutrients do not appear to be related to the biological findings in liver or mesenteric lymph nodes. However, because of the magnitude of serum vitamin E reductions, the nutritional status of animals treated with white oils may become a more important factor for studies of longer duration.
In conclusion, 90-day dietary studies in F-344 rats with white oils and waxes produced an inflammatory response in liver and mesenteric lymph nodes that appeared to be related to molecular size and absorption of the hydrocarbons. In addition, one new finding was the occurrence of an inflammation of the cardiac mitral valve, which was observed in rats treated with the high doses of paraffin waxes. The magnitude of the inflammatory responses appears to be unique to the F-344 rat based on a survey of other reported studies on similar materials. These data suggest that there are significant species and strain differences in biological responses to mineral hydrocarbons and that further evaluation is needed to establish whether or not the findings in F-344 rats are relevant for human health risk assessment. A proper human health risk as-sessment should consider the species/strain differences in these and other reported studies and the historical safe human exposure to the mineral hydrocarbon products in food, pharmaceutical, and cosmetic applications for over four decades.
